Reference
Brolucizumab (Pagenax): Risk of Intraocular Inflammation, Including Retinal Vasculitis and/or Retinal Vascular Occlusion (Updated Recommendations to Minimise the Known Risks) Internet Document : 6 Oct 2022. Available from: URL: https://bit.ly/3M8g2oa
Rights and permissions
About this article
Cite this article
Minimising brolucizumab-related retinal vasculitis, retinal vein occlusion. Reactions Weekly 1928, 4 (2022). https://doi.org/10.1007/s40278-022-25269-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-022-25269-x